GS7.DE

GlaxoSmithKline plc [GS7.DE] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

GS7.DE Stock Summary

In the News

GS7.DE Financial details

Company Rating
Strong Buy
Market Cap
0
Income
5.21B
Revenue
35.31B
Book val./share
5.04
Cash/share
2.01
Dividend
-
Dividend %
-
Employees
90.1K
Optionable
No
Shortable
Yes
Earnings
-
P/E
13.84
Forward P/E
-
PEG
-8.75
P/S
-
P/B
4.68
P/C
-
P/FCF
-
Quick Ratio
0.18
Current Ratio
0.79
Debt / Equity
1.35
LT Debt / Equity
1.15
-
-
EPS (TTM)
1.33
EPS next Y
-
EPS next Q
-
EPS this Y
-18.99%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
18.4%
Revenue last 5Y
2.48%
Revenue Q/Q
-29.15%
EPS Q/Q
-56.6%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
6%
ROE
34%
ROC
0.1%
Gross Margin
66%
Oper. Margin
16%
Profit Margin
15%
Payout
78%
Shs Outstand
4.07B
Shs Float
4.89B
-
-
-
-
Target Price
-
52W Range
-
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
-
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.253953
-
-
Volatility
0.13%, 0.13%
Prev Close
-
Price
-
Change
-

GS7.DE Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
7.727.758.418.468.57
Net income per share
0.551.021.311.581.28
Operating cash flow per share
1.772.1222.092
Free cash flow per share
1.211.671.461.541.26
Cash per share
111.191.531.09
Book value per share
-0.021.12.843.623.78
Tangible book value per share
-5.07-4.86-5.77-4.87-4.85
Share holders equity per share
-0.021.12.843.623.78
Interest debt per share
4.566.757.826.956.27
Market cap
71.59B73.83B70.61B74.91B68.76B
Enterprise value
84.85B96.02B96.41B95.97B88.66B
P/E ratio
33.0118.2513.411.7313.49
Price to sales ratio
2.372.42.092.22.02
POCF ratio
10.358.778.88.878.65
PFCF ratio
15.1811.1412.0612.0813.69
P/B Ratio
-1.05K16.936.195.144.57
PTB ratio
-1.05K16.936.195.144.57
EV to sales
2.813.122.862.812.6
Enterprise value over EBITDA
15.313.7110.9310.0611.03
EV to operating cash flow
12.2611.412.0211.3711.15
EV to free cash flow
17.9914.4916.4615.4717.66
Earnings yield
0.030.050.070.090.07
Free cash flow yield
0.070.090.080.080.07
Debt to equity
-251.315.982.671.861.61
Debt to assets
0.30.450.380.340.31
Net debt to EBITDA
2.393.172.932.212.48
Current ratio
0.60.750.810.910.79
Interest coverage
4.926.687.338.397.03
Income quality
4.522.321.731.471.81
Dividend Yield
0.050.050.060.050.06
Payout ratio
1.80.970.750.620.78
Sales general and administrative to revenue
0.320.320.340.340.32
Research and developement to revenue
0.150.130.140.150.15
Intangibles to total assets
0.410.40.520.50.51
Capex to operating cash flow
-0.32-0.21-0.27-0.27-0.37
Capex to revenue
-0.07-0.06-0.06-0.07-0.09
Capex to depreciation
-1.15-0.97-0.93-0.95-1.16
Stock based compensation to revenue
0.010.010.010.010
Graham number
0.475.019.1611.3610.44
ROIC
0.130.140.130.150.13
Return on tangible assets
0.070.120.140.160.13
Graham Net
-11.82-11.99-13.35-12.52-12.69
Working capital
-10.66B-5.56B-4.56B-1.9B-5B
Tangible asset value
-19.81B-19.32B-23.16B-19.61B-19.29B
Net current asset value
-36.99B-37.47B-41.84B-39.38B-39.09B
Invested capital
-251.315.982.671.861.61
Average receivables
00000
Average payables
3.56B3.59B3.89B4.25B10.96B
Average inventory
5.33B5.52B5.71B5.97B5.89B
Days sales outstanding
00000
Days payables outstanding
124.51129.91127.5135.88552.2
Days of inventory on hand
196.12195.17182.98186.99181.92
Receivables turnover
00000
Payables turnover
2.932.812.862.690.66
Inventory turnover
1.861.871.991.952.01
ROE
-31.90.930.460.440.34
Capex per share
-0.56-0.45-0.54-0.56-0.74

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.022.272.382.412.13
Net income per share
0.380.340.230.530.23
Operating cash flow per share
0.320.640.940.630.5
Free cash flow per share
0.160.320.780.480.37
Cash per share
0.890.881.083.452.01
Book value per share
3.843.853.763.995.04
Tangible book value per share
-4.54-4.76-4.81-4.571.65
Share holders equity per share
3.843.853.763.995.04
Interest debt per share
6.416.446.088.276.86
Market cap
70.91B70.59B69.2B70.34B57.66B
Enterprise value
92.89B92.75B89.1B92.7B73.3B
P/E ratio
11.5312.918.68.1219.32
Price to sales ratio
8.767.787.267.198.32
POCF ratio
54.8827.5518.3727.6735.26
PFCF ratio
112.3755.2422.0736.2447.69
P/B Ratio
4.614.584.64.353.52
PTB ratio
4.614.584.64.353.52
EV to sales
11.4810.229.359.4810.58
Enterprise value over EBITDA
42.5533.9272.529.4440.21
EV to operating cash flow
71.8936.223.6536.4744.83
EV to free cash flow
147.2172.5728.4247.7660.63
Earnings yield
0.020.020.010.030.01
Free cash flow yield
0.010.020.050.030.02
Debt to equity
1.661.661.612.061.35
Debt to assets
0.330.330.310.370.25
Net debt to EBITDA
10.078.116.197.18.58
Current ratio
0.820.810.791.191.43
Interest coverage
7.918.743.7511.535.84
Income quality
0.932.195.031.411.95
Dividend Yield
0.020.010.010.010.02
Payout ratio
0.750.71.020.441.55
Sales general and administrative to revenue
0.330.290.340.290.3
Research and developement to revenue
0.150.160.150.120.18
Intangibles to total assets
0.520.520.510.460.19
Capex to operating cash flow
-0.51-0.5-0.17-0.24-0.26
Capex to revenue
-0.08-0.14-0.07-0.06-0.06
Capex to depreciation
-1-1.3-1.23-0.85-0.68
Stock based compensation to revenue
00000
Graham number
5.765.444.436.935.1
ROIC
0.040.030.020.040.03
Return on tangible assets
0.040.040.020.040.01
Graham Net
-12.17-12.56-12.61-12.35-17.7
Working capital
-3.82B-4.16B-5B4.71B16.35B
Tangible asset value
-18.19B-19.08B-19.29B-18.54B5.36B
Net current asset value
-37.87B-38.69B-39.09B-38.07B-12.22B
Invested capital
1.661.661.612.061.35
Average receivables
00000
Average payables
14.44B14.75B16.39B17.57B16.19B
Average inventory
6.27B6.29B6.01B5.89B5.33B
Days sales outstanding
00000
Days payables outstanding
502.75474.45429.31428.71612.38
Days of inventory on hand
223.06194.52141.43146.41192.9
Receivables turnover
00000
Payables turnover
0.180.190.210.210.15
Inventory turnover
0.40.460.640.610.47
ROE
0.10.090.060.130.05
Capex per share
-0.17-0.32-0.16-0.15-0.13

GS7.DE Frequently Asked Questions

What is GlaxoSmithKline plc stock symbol ?

GlaxoSmithKline plc is a GB stock and trading under the symbol GS7.DE

What is GlaxoSmithKline plc stock quote today ?

GlaxoSmithKline plc stock price is $- today.

Is GlaxoSmithKline plc stock public?

Yes, GlaxoSmithKline plc is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Similar Market Cap